Feb 17, 2006 /PRNewswire-FirstCall via COMTEX/ -- NutraCea (OTC Bulltin Board: NTRZ), a leader in stabilized rice bran research and development, announced the hire of Dr. Rani Madhavapeddi Patel as Chief Science Officer.
"We're delighted to have Dr. Patel join the NutraCea team. Her outstanding track record and well rounded background in maternal and childhood nutrition will add immediate strength and strategic leadership to our organization. Dr. Patel comes to NutraCea with diverse experience and unique skill sets that will help position us as an industry leader. Her experience reinforces the Company's commitment to quality and innovation as we scale up the size and breadth of the organization and increase product distribution, "said Brad Edson, CEO and President of NutraCea.
"I am very excited to join NutraCea and be a part of a company committed to alleviation of global hunger. I feel fortunate to be joining the Company at a very exciting stage of accelerated growth and opportunities. I am looking forward to fully utilizing my research skills and expertise in maternal and child nutrition to make significant contributions to our shared vision for combating global malnutrition. It is wonderful to be working for a company whose vision and mission is based on idealism!" stated Dr. Patel.
Dr. Rani Madhavapeddi Patel has a strong academic and industry background, which includes a unique blend of research, public health, teaching and nutraceutical industry knowledge. She has a Ph.D in Nutrition and her work on energy expenditure of Lactating Women is one of the first of its kind in the world, which establishes the energy requirements of lactating women. Dr. Patel's clinical research has been published in over 18 peer reviewed nutritional journals and her work is quoted in various textbooks on nutrition. She worked with the World Health Organization on the metabolic side effects of oral medications. At the Texas Department of Health as a Program Manager for the chronic disease prevention program in collaboration with the Centers for Disease Control, she worked on national surveys like the Youth Behavioral Risk Surveillance and the Youth Tobacco Study. She also worked with the Cooper Institute on the energy expenditure of school students. She was the co- coordinator of the Continuous Quality Control Committee and taught CQI to TDH staff. She has won awards for her commitment to quality control and public health.
Her work with the FAO/WHO funded project on "Micronutrient deficiencies" won her the prestigious Sagarmal Goenka award. She has presented her scientific work at several international scientific conferences and was an invited speaker at the FAO/WHO/NIN sponsored conference on Micronutrient Deficiencies. She taught classes on world nutrition and hunger at San Jose State University. Before she came to NutraCea she worked at Matthias Rath Inc. in Santa Clara, CA. Dr. Patel is committed to preventive health and nutrition and has a certification in Ayurveda from the American Institute of Ayurveda.
NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through it's wholly owned subsidiary RiceX, the company manufacturers as well as distributes products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual property to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by- product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health-promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the company's filings with the SEC and you can visit the NutraCea web site http://www.NutraCea.com .
Forward Looking Statements
This release contains forward-looking statements. Actual results may differ from those projected due to a number of risks and uncertainties, including, but not limited to the matters specified in the Company's filings with the Securities and Exchange Commission. These statements are made based upon current expectations that are subject to risk and uncertainty. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report.